|
|
||||||||
Clinical and Research Reports |
Received May 11, 2000; revised September 6, 2000; accepted October 10, 2000. From the University of Maryland Department of Psychiatry. Address correspondence to Dr. Regenold, University of Maryland Medical Center, Box #351, Room S12A09, 22 South Greene Street, Baltimore, MD 21201.
The authors describe the use of intravenous sodium valproate (Depacon®) to treat three geriatric inpatients: two acutely manic patients who refused oral medication and one dementia patient with agitation and dysphagia receiving end-of-life care for Alzheimer's disease.
Key Words: Bipolar Disorder Alzheimer's Disease Valproate
This article has been cited by other articles:
![]() |
K. Semion, J. Dorsey, and J. Bourgeois Intravenous Valproate Use in Bipolar II Disorder After Gastric Bypass Surgery J Neuropsychiatry Clin Neurosci, August 1, 2005; 17(3): 427 - 429. [Full Text] [PDF] |
||||
![]() |
J. A. Bourgeois, A. K. Koike, J. E. Simmons, S. Telles, and C. Eggleston Adjunctive Valproic Acid for Delirium and/or Agitation on a Consultation-Liaison Service: A Report of Six Cases J Neuropsychiatry Clin Neurosci, May 1, 2005; 17(2): 232 - 238. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Young, L. Gyulai, B. H. Mulsant, A. Flint, J. L. Beyer, K. I. Shulman, and C. F. Reynolds III Pharmacotherapy of Bipolar Disorder in Old Age: Review and Recommendations Am J Geriatr Psychiatry, August 1, 2004; 12(4): 342 - 357. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ALL ISSUES | SEARCH | TABLE OF CONTENTS |